|
|
Volumn 6, Issue 5, 2010, Pages 245-246
|
|
Hyperkalemia: A threat to RAAS inhibition?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCINEURIN INHIBITOR;
DIURETIC AGENT;
HEPARIN;
MINERALOCORTICOID RECEPTOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
POTASSIUM ION;
RENIN INHIBITOR;
SPIRONOLACTONE;
CHRONIC KIDNEY DISEASE;
DIABETES MELLITUS;
EDITORIAL;
HEART DISEASE;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
INFLAMMATION;
KIDNEY FUNCTION;
LIVER DISEASE;
METABOLIC SYNDROME X;
OXIDATIVE STRESS;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ALDOSTERONE ANTAGONISTS;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DRUG INTERACTIONS;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERKALEMIA;
RENIN-ANGIOTENSIN SYSTEM;
SPIRONOLACTONE;
|
|
EID: 77951781426
PISSN: 17595061
EISSN: 1759507X
Source Type: Journal
DOI: 10.1038/nrneph.2010.52 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
